Top Headlines and Trials from 2016: Time for Change?

Dr. Katelyn Halpape, BSP, PharmD, ACPR
Clinical Pharmacy Specialist – Neurosciences, Vancouver General Hospital
This presentation will review the key studies and headlines from 2016 and how we can apply this information to practice.

Trials Reviewed:
HOPE-3 (Cholesterol & BP Lowering)
EMPA-REG (Type 2 Diabetes)
LEADER (Type 2 Diabetes)
ATTACH-II (Intracranial Hemorrhage)

Handout